Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TTP Labtech Brings Automated Biobanking to SLAS

Published: Wednesday, December 12, 2012
Last Updated: Wednesday, December 12, 2012
Bookmark and Share
Low cost, low footprint biobanking systems protect samples from submission to screening.

TTP Labtech will showcase its affordable and compact automated biobanking systems at the upcoming SLAS 2013 conference and exhibition in Orlando, FL, USA from 12-16 January.

The company will be demonstrating the unique benefits of comPOUND® and arktic™ fully automated storage modules and its lab2lab® sample transport solution.

As part of the biobanking sample management workflow the fully automated capper, decapper and mosquito®, the low volume liquid pipetting solution for assay preparation and miniaturization, will also be demonstrated.

TTP Labtech’s complete system ensures increased sample integrity in a fully automated workflow from sample storage to screening.

As sample libraries increase in both small research groups and large corporations, there is a growing need for affordable, low footprint and contamination-free automated biobanking systems for processes such as plasmid production, whole blood extraction and storage, forensics, protein storage and tumour banking.

Manual sample handling is time-consuming, laborious and error prone and this, combined with large space consuming storage units puts a strain on research facilities.

Cross-contamination is also a frequent risk and sample integrity can be compromised by regular freeze/thaw cycles.

TTP Labtech has answered this need with the development of its comPOUND (ambient to -20°C) and arktic (-80°C) automated storage modules. These are capable of storing up to 3 times the number of samples of a standard -80°C freezer within almost the same physical space.

The storage modules have no moving parts within the cold zone, instead relying on TTP Labtech’s proprietary pneumatic transport technology.

Samples are stored individually under nitrogen or dry air in hermetically sealed chambers eliminating contamination worries and improving sample stability.

The lack of moving parts ensures robust unit longevity and automation with air further safeguards sample integrity by enabling fast and efficient cherry picking, avoiding the unnecessary freeze/thaw cycles that are incurred when a whole plate is removed.

Sample submission to these units is fast, simple and accurate thanks to simple barcoding and LIMS (Laboratory Information Management System) integration.

TTP Labtech’s pneumatic transport system ensures full chain of custody through the connection of these remote storage units to laboratories via its lab2lab system.

This small, bench-top microtube sender is capable of easily transporting sample microtubes 1000m or further, enabling researchers in remote laboratories to safely and quickly submit samples to multiple storage facilities elsewhere.

Assay set-up and analysis can then be further automated by the use of systems such as the TTP Labtech decapper, for fully automated decapping of racks of up to 96 tubes within 90 seconds, and the mosquito HTS and mosquito HV for automated assay miniaturization.

TTP Labtech will exhibit comPOUND, arktic, lab2lab, mosquito and capper/decapper at booth 1213 at SLAS 2013.

For a chance to win a new mini iPad amongst other prizes, visitors can test TTP Labtech’s biobanking automation with air by entering a “Tube Prize Draw”.

Barcoded tubes will be scanned and sent from the lab2lab unit to arktic, with winning tubes randomly drawn from the arktic at the end of the day.

TTP Labtech’s innovative arktic automated -80°C storage module will also be presented in the highly interactive Late Night with LRIG (Laboratory Robotics Interest Group) forum on Monday January 14 at 7-9pm, where attendees will have the opportunity to discuss and learn about the latest innovations in laboratory automation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

David Newble Joins TTP Labtech as New Managing Director
Recent appointment promises to drive innovation strategy and further strengthen R&D pipeline
Thursday, June 18, 2015
TTP Labtech and Almac Group’s Form Strategic Alliance
Alliance consolidates fluorescence lifetime technology to form a one-stop shop for compound screening.
Thursday, February 05, 2015
Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined
Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.
Saturday, July 19, 2014
TTP Labtech Revenues up 43%
The company has reported an impressive 43% increase in revenues and an associated increase in profits over 2013.
Monday, June 23, 2014
TTP Labtech Acquires Assets from AssayMetrics
Significant improvements in assay reagents and availability of HTS-compatible readers has propelled fluorescence lifetime technology to the vanguard of cost-effective screening technologies.
Thursday, January 09, 2014
Major Protein Structure Discovery Achieved Using TTP Labtech’s Mosquito LCP
Researchers have successfully reported the structure of a Class B G-Protein Coupled Receptor (GPCR) using lipidic cubic phase (LCP) protein crystallisation.
Friday, July 26, 2013
TTP Labtech Announces On-Going Growth
An investment of £3.8M in global R&D sees product sales grow over 20%.
Thursday, July 11, 2013
TTP Labtech Announces Company Growth
New product offering demonstrates strong commitment to product development.
Friday, May 11, 2012
Driving the Science of the Future
TTP LabTech announce that they are founding sponsors of the inaugural European Lab Automation (ELA) conference and exhibition, to be held at the Conference Centre Hamburg (CCH), Hamburg, Germany, from the 30th June-1st July.
Friday, May 20, 2011
Increased Demand Drives Queensland Compound Library Expansion
QCL capacity is increased by the acquisition of a fourth additional comPOUND® storage module.
Thursday, June 10, 2010
Improve your screening know-how with TTP LabTech at Screening Europe 2010
This year at Screening Europe 2010, TTP LabTech will be sharing its in-house expertise and technical advice with exhibition delegates in order to further improve current high content screening techniques and workflows.
Thursday, January 28, 2010
TTP LabTech Delivers Automated Chemistry System for Salt and Polymorph Screening to AstraZeneca
The three year laboratory automation project involved the design and build of a fully automated system for salt and polymorph screening of novel compounds.
Wednesday, January 28, 2009
TTP LabTech's European Roadshow
The roadshow offers the opportunity to try out the latest in low-volume liquid handling and high content screening systems, as well as learning more about compound management, instrumentation development and custom automation.
Thursday, September 13, 2007
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
TTP LabTech further expands its US facilities with the recruitment of sales and customer service personnel for its East Coast office in Cambridge, MA.
Monday, July 30, 2007
TTP Extends Global Reach
After building up a strong base of customers in the USA and Europe over the past three years, TTP LabTech have now appointed distributors for Japan, India and Australia/New Zealand.
Wednesday, April 04, 2007
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!